A recent article by Frea et al 1 in HeartRhythm provides new evidence for altered systolic function in patients with the short QT syndrome (SQTS). They studied 15 patients with the SQTS (7 with the hERG mutation-linked SQT1 variant, 3 with KCNQ1 mutation-linked SQT2 variant, and 5 without known mutations) by using tissue Doppler imaging and speckle tracking electrocardiography to reveal reduced left ventricular contraction and increased mechanical dispersion in the SQTS group as compared with healthy controls. 1 A longer myocardial performance index was seen in patients with the SQTS, but without significant alterations in isovolumetric contraction and relaxation times, implying that this results from reduced ejection time. Over half of the patients with the SQTS also displayed pathological values of global longitudinal shortening, which correlated positively with corrected QT interval shortening. 1 Mechanical dispersion affected the final stage of contraction in patients with the SQTS. 1 In 2013, we published a simulation study in which the functional effects of SQTS K þ channel mutations were incorporated into human ventricular electromechanical models. 2 The incorporation of the SQT1 N588K hERG mutation profoundly reduced the intracellular calcium transient, leading to greatly reduced active force. The SQT3 D172N Kir2.1 mutation, which predominantly influences late repolarization, produced a more modest effect. 2 Once stretch-activated channels (SACs) were incorporated into the base model, the effects of the SQT mutations on the Ca 2þ transient and force generation were reduced and reduced further if SAC Ca 2þ permeability was incorporated. 2 Under simulated action potential clamp, shorter action potentials led to a reduced sarcoplasmic reticulum Ca 2þ content and Ca 2þ transients in the control model, implicating abbreviated repolarization itself as a driver of altered contractility; the mitigating effects of SAC incorporation correlated with changes in Na þ homeostasis and sodium-calcium exchange (NCX) activity. 2 The extent to which mechanisms demonstrated in our "proof-ofconcept" simulations, made in the absence of any compensatory remodeling, apply to the modest but significant systolic dysfunction in patients with the SQTS 1 remains to be established. However, given the important findings of Frea et al, 1 further investigation of altered mechanical function in the SQTS is now warranted. Reply to the Editor-Altered in vivo systolic function in the short QT syndrome anticipated in silicoOur group recently demonstrated an in vivo association between short QT syndrome (SQTS) and a slight but significant systolic dysfunction. 1 Hancox and colleagues 2 partially anticipated this report showing an interesting correlation between SQTS channel mutations (mostly HERG mutation) and shortening of action potential with an in vitro reduction in Ca 2þ transient and force generation. These 2 studies seem to suggest that the association between SQTS and systolic impairment may be explained by 3 mechanisms: a greater...